The company aims to start human trials after this summer Italian biotech firm Takis has claimed that their vaccine candidate has become one of the first to successfully neutralize the SARS-CoV2 virus in animal models. “This is the most advanced stage of testing of a candidate vaccine created in Italy.
As far as we know, we are among the first in the world to have demonstrated the neutralization of the coronavirus by a vaccine.
We believe this will also happen in humans," said Luigi Aurisicchio, chief executive officer (CEO), Takis. The company aims to start human trials after this summer.
It had shortlisted five vaccine candidates for experimental validation at the popular Spallanzani National Institute for Infectious Diseases in Rome on